​

Adial Pharmaceuticals Ownership | Who Owns Adial Pharmaceuticals?

OverviewFinancialsChart

Adial Pharmaceuticals Ownership Summary

Adial Pharmaceuticals is owned by 0.06% institutional investors, 1.78% insiders, and 98.16% retail investors. 1620 investment advisors is the largest institutional shareholder, holding 0.06% of ADIL shares. Fidelity Extended Market Index is the top mutual fund, with 0.53% of its assets in Adial Pharmaceuticals shares.

ADIL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdial Pharmaceuticals0.06%1.78%98.16%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
1620 investment advisors3.60K0.06%$3.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
1620 investment advisors3.60K0.00%$3.64K

Top Buyers

HolderShares% AssetsChange
1620 investment advisors3.60K0.00%3.60K

Top Sellers

HolderShares% AssetsChange
1620 investment advisors3.60K0.00%3.60K

New Positions

HolderShares% AssetsChangeValue
1620 investment advisors3.60K0.00%3.60K$3.64K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-3,600---1---
Jun 30, 202317-10.53%2,253,587-6.89%810.18%3-57.14%6-
Mar 31, 202319-2,420,24052.08%922.64%7-12.50%6100.00%
Dec 31, 202219-5.00%1,591,440-15.48%611.86%8-20.00%350.00%
Sep 30, 202220-23.08%1,882,92316.72%716.63%10-33.33%2-33.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index34.63K0.53%-279.00
BlackRock Extended Equity Market K17.57K0.27%-7.00
Extended Equity Market Fund K17.33K0.27%-239.00
Spartan Extended Market Index Pool E10.30K0.16%9.29K
Vanguard Institutional Extnd Mkt Idx Tr9.36K0.14%-
Fidelity Series Total Market Index9.16K0.14%-
Fidelity Total Market Index7.75K0.12%-
Extended Equity Market Fund M2.25K0.03%22.00
Fidelity Nasdaq Composite Index661.000.01%-
Northern Trust Extended Eq Market Idx598.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 29, 2023Schuyler Kevin-Buy$1.92K
Dec 30, 2021Newman James W. Jr.-Buy$27.10K
Dec 30, 2021Newman James W. Jr.-Buy$13.60K
Dec 30, 2021Newman James W. Jr.-Buy$26.60K
Nov 30, 2021Stilley William B. III Chief Executive OfficerBuy$29.18K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q1--
2023 Q31-
2023 Q2--
2022 Q4--

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals shareholders are primarily institutional investors at 0.06%, followed by 1.78% insiders and 98.16% retail investors. The average institutional ownership in Adial Pharmaceuticals's industry, Biotech Stocks , is 69.02%, which Adial Pharmaceuticals falls below.

Does Blackrock own Adial Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adial Pharmaceuticals.

Who is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

1620 investment advisors is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 3.6K Adial Pharmaceuticals shares, valued at 3.64K$.

Who is the top mutual fund holder of Adial Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Adial Pharmaceuticals shares, with 0.53% of its total shares outstanding invested in 34.63K Adial Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools